The effectiveness and safety of mycophenolate mofetil in lupus nephritis

ISSN： 0770-3198

Source： Clinical Rheumatology, Vol.28, Iss.7, 2009-07, pp. : 835-840

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

The efficacy of low-dose mycophenolate mofetil for treatment of lupus nephritis in Taiwanese patients with systemic lupus erythematosus

By Weng Meng-Yu Weng Chia-Tse Liu Ming-Fei

Clinical Rheumatology, Vol. 29, Iss. 7, 2010-07 ,pp. : 771-775

Springer Publishing Company

Access to resources Recommend Favorite

Mycophenolate mofetil for non-renal manifestations of systemic lupus erythematosus: a systematic review

By Mok C. C.

Scandinavian Journal of Rheumatology, Vol. 36, Iss. 5, 2007-01 ,pp. : 329-337

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and safety of tacrolimus for induction therapy in patients with active lupus nephritis

By Takahashi Satoshi

Modern Rheumatology, Vol. 21, Iss. 3, 2011-06 ,pp. : 282-289

Springer Publishing Company

Access to resources Recommend Favorite

Safety and efficacy of infliximab in a patient with active WHO class IV lupus nephritis

By Hayat Sawsan Uppal Sukhbir Narayanan Nampoory M. Johny Kaivilayil Gupta Ramkumar Al-Oun Mohammed

Clinical Rheumatology, Vol. 26, Iss. 6, 2007-06 ,pp. : 973-975

Springer Publishing Company

Access to resources Recommend Favorite

Mycophenolate Mofetil: A New Immunosuppressive ApproachSuccessful Treatment in a Case of Myasthenia gravis Associated with Incomplete Lupus erythematosus Syndrome and Hepatitis C Virus Infection

European Neurology, Vol. 46, Iss. 1, 2001-07 ,pp. : 53-54

Karger

Access to resources Recommend Favorite